贺丽辉,王 永

带状疱疹是一种由病毒感染的皮肤病，其最严重的后果是带状疱疹后遗神经痛，影响患者的生活质量。而对于带状疱疹的治疗方案现在已逐渐的成熟，但是随着时代科研的进步，更多的治疗方案和药物不断在出现，本文是对此的一个归纳总结，旨在为广大临床工作者以及患者提供参考。

带状疱疹；药物；激光；治疗

[1] Gershon AA, Breuer J, Cohen JI, et al. Varicella zoster virus infection[J]. Nat Rev Dis Primers, 2015, 1: 15016. [2] Li Puma DD, Marcocci ME, Lazzarino G, et al. Ca2+ -dependent release of ATP from astrocytes affects herpes simplex virus type 1 infection of neurons[J]. Glia, 2021, 69(1): 201-215. [3] Le P, Rothberg M. Herpes zoster infection[J]. BMJ, 2019, 364: k5095. [4] Patil A, Goldust M, Wollina U. Herpes zoster: A Review of Clinical Manifestations and Management[J]. Viruses, 2022, 14(2): 192. [5] Johnson RW, Rice ASC. Postherpetic Neuralgia[J]. N Engl J Med, 2014, 371(16): 1526-1533. [6] Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults[J]. N Engl J Med, 2005, 352(22): 2271-2284. [7] Szyk P, Czarczynska-Goslinska B, Mlynarczyk DT, et al. Polymer-Based Nanoparticles as Drug Delivery Systems for Purines of Established Importance in Medicine[J]. Nanomaterials, 2023, 13(19): 2647. [8] Nair AB, Attimarad M, Al-Dhubiab BE, et al. Enhanced oral bioavailability of acyclovir by inclusion complex using hydroxypropyl-β-cyclodextrin[J]. Drug Delivery, 2014, 21(7): 540-547. [9] Cohen EJ, Jeng BH. Herpes Zoster: A Brief Definitive Review[J]. Cornea, 2021, 40(8): 943-949. [10] Bodilsen J, Nielsen H, Whitley RJ. Valaciclovir therapy for herpes encephalitis: caution advised[J]. Journal of Antimicrobial Chemotherapy, 2019, 74(6): 1467-1468. [11] Andrei G, Topalis D, Fiten P, et al. In Vitro -Selected Drug-Resistant Varicella-Zoster Virus Mutants in the Thymidine Kinase and DNA Polymerase Genes Yield Novel Phenotype-Genotype Associations and Highlight Differences between Antiherpesvirus Drugs[J]. J Virol, 2012, 86(5): 2641-2652. [12] Oka T, Hishizawa M, Yamashita K, et al. Successful treatment with famciclovir for varicella zoster virus infection resistant to acyclovir[J]. Journal of Infection and Chemotherapy, 2021, 27(5): 755-758. [13] Hasegawa T, Kurokawa M, Yukawa TA, et al. Inhibitory action of acyclovir (ACV) and penciclovir (PCV) on plaque formation and partial cross-resistance of ACV-resistant varicella-zoster virus to PCV[J]. Antiviral Res, 1995, 27(3): 271-279. [14] Crumpacker C. The pharmacological profile of famciclovir[J]. Semin Dermatol, 1996, 15(2 Suppl 1): 14-26. [15] De Clercq E. Discovery and development of BVDU (brivudin) as a therapeutic for the treatment of herpes zoster[J]. Biochem Pharmacol, 2004, 68(12): 2301-2315. [16] De Clercq E, Descamps J, Ogata M, et al. In vitro susceptibility of varicella-zoster virus to E-5-(2-bromovinyl)-2’-deoxyuridine and related compounds[J]. Antimicrob Agents Chemother, 1982, 21(1): 33-38. [17] Hwang-Bo J, Kim B, Park DW, et al. Safety, tolerability of ES16001, a novel varicella zoster virus reactivation inhibitor, in healthy adults[J]. Eur J Med Res, 2021, 26(1): 92. [18] Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision[J]. Euro J of Neurology, 2010, 17(9): 1113. [19] Sawynok J. Topical analgesics for neuropathic pain: Preclinical exploration, clinical validation, future development[J]. European Journal of Pain, 2014, 18(4): 465-481. [20] Schifano F. Misuse and abuse of pregabalin and gabapentin: cause for concern?[J]. CNS Drugs, 2014, 28(6): 491-496. [21] Gajraj NM. Pregabalin: Its Pharmacology and Use in Pain Management[J]. Anesthesia & Analgesia, 2007, 105(6): 1805-1815. [22] Bockbrader HN, Wesche D, Miller R, et al. A Comparison of the Pharmacokinetics and Pharmacodynamics of Pregabalin and Gabapentin:[J]. Clinical Pharmacokinetics, 2010, 49(10): 661-669. [23] Üçeyler N, Sommer C. High-Dose Capsaicin for the Treatment of Neuropathic Pain: What We Know and What We Need to Know[J]. Pain Ther, 2014, 3(2): 73-84. [24] Derry S, Rice AS, Cole P, et al. Topical capsaicin (high concentration) for chronic neuropathic pain in adults[J]. Cochrane Database of Systematic Reviews, 2017, 2021(7). [25] Gaul C, Resch S. Application of the capsaicin 8% cutaneous patch in neuropathic pain of the head and face: A case series[J]. Cephalalgia, 2015, 35(6): 545-550. [26] Wolff RF, Bala MM, Westwood M, et al. 5% lidocaine-medicated plaster vs other relevant interventions and placebo for post-herpetic neuralgia (PHN): a systematic review[J]. Acta Neurol Scand, 2011, 123(5): 295-309. [27] Shiraki K, Yasumoto S, Toyama N, et al. Amenamevir, a Helicase-Primase Inhibitor, for the Optimal Treatment of Herpes Zoster[J]. Viruses, 2021, 13(8): 1547. [28] Shiraki K, Tan L, Daikoku T, et al. Viral ribonucleotide reductase attenuates the anti-herpes activity of acyclovir in contrast to amenamevir[J]. Antiviral Research, 2020, 180: 104829. [29] Yajima M, Yamada H, Takemoto M, et al. Profile of anti-herpetic action of ASP2151 (amenamevir) as a helicase-primase inhibitor[J]. Antiviral Research, 2017, 139: 95-101. [30] Chung H, Dai T, Sharma SK, et al. The Nuts and Bolts of Low-level Laser (Light) Therapy[J]. Ann Biomed Eng, 2012, 40(2): 516-533. [31] Walker J. Relief from chronic pain by low power laser irradiation[J]. Neuroscience Letters, 1983, 43(2-3): 339-344. [32] Lim W, Lee S, Kim I, et al. The anti‐inflammatory mechanism of 635 nm light‐emitting‐diode irradiation compared with existing COX inhibitors[J]. Lasers Surg Med, 2007, 39(7): 614-621. [33] Mozzati M, Martinasso G, Cocero N, et al. Influence of Superpulsed Laser Therapy on Healing Processes Following Tooth Extraction[J]. Photomedicine and Laser Surgery, 2011, 29(8): 565-571. [34] Houreld NN, Sekhejane PR, Abrahamse H. Irradiation at 830 nm stimulates nitric oxide production and inhibits pro‐inflammatory cytokines in diabetic wounded fibroblast cells[J]. Lasers Surg Med, 2010, 42(6): 494-502. [35] Muñoz Sanchez PJ, Capote Femenías JL, Díaz Tejeda A, et al. The Effect of 670-nm Low Laser Therapy on Herpes Simplex Type 1[J]. Photomedicine and Laser Surgery, 2012, 30(1): 37-40. [36] Schindl A, Neumann R. Low-Intensity Laser Therapy is an Effective Treatment for Recurrent Herpes Simplex Infection. Results from a Randomized Double-Blind Placebo-Controlled Study[J]. Journal of Investigative Dermatology, 1999, 113(2): 221-223. [37] Chen YT, Wang HH, Wang TJ, et al. Early application of low-level laser may reduce the incidence of postherpetic neuralgia (PHN)[J]. Journal of the American Academy of Dermatology, 2016, 75(3): 572-577. [38] Rijsdijk M, Van Wijck AJM, Kalkman CJ, et al. The Effects of Glucocorticoids on Neuropathic Pain: A Review with Emphasis on Intrathecal Methylprednisolone Acetate Delivery[J]. Anesthesia & Analgesia, 2014, 118(5): 1097-1112.

点击下载PDF